Biosimilars Market Research Reports & Industry Analysis
The worldwide prescription generic drug market has stood the test of time and has endured numerous growing pains. However, it has evolved into a formidable and important participant in the complex world of health care. Generic drugs continue to represent one of the greatest values in healthcare and are of great importance in the area of biopharmaceuticals as well because these products are among the most expensive treatments currently on the market.
Generic drug manufacturers are poised for strong growth in the future because the patent protection for a host of major biopharmaceuticals will expire and new legislative reforms in the generic drug approval process may facilitate bringing products to market. While there are many issues to address, the outlook for the promotion of biosimilars is favorable in the next five years.
Biosimilars Industry Research & Market Reports
-
Global Remicade Biosimilar Market Growth 2023-2029
... research report, the “Remicade Biosimilar Industry Forecast” looks at past sales and reviews total world Remicade Biosimilar sales in 2022, providing a comprehensive analysis by region and market sector of projected Remicade Biosimilar sales for ... Read More
-
U.S. Biopharmaceutical CMO & CRO Market Size, Share & Trends Analysis Report By Source (Mammalian, Non-mammalian), By Service (Contract Manufacturing, Contract Research), By Product (Biologics, Biosimilars), And Segment Forecasts, 2023 - 2030
... & CRO Market Growth & Trends The U.S. biopharmaceutical CMO & CRO market size is expected to reach USD 16.7 billion by 2030, expanding at a CAGR of 6.1% during the forecast period, according to ... Read More
-
Biosimilars Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Disease Indication (Cancer, Diabetes, Autoimmune Diseases, and Other Diseases), Drug Class (Granulocyte Colony-Stimulating Factors, Human Growth Hormone, Insulin, TNF Blockers & Monoclonal Antibodies, Erythropoietin-Stimulating Agents, and Others), Route of Administration (Intravenous, Subcutaneous, and Others), and End User (Hospitals, Speciality Clinics, Homecare, and Others)
... Erythropoietin-Stimulating Agents, and Others), Route of Administration (Intravenous, Subcutaneous, and Others), and End User (Hospitals, Speciality Clinics, Homecare, and Others) The biosimilars market was valued at US$ 18,435.89 million in 2021 and is expected to ... Read More
-
Global Biosimilar Testing Service Market Growth (Status and Outlook) 2023-2029
... options. Biosimilar have a unique properties, which is used to study the biological functions and structures complexity of the sample. LPI (LP Information)' newest research report, the “Biosimilar Testing Service Industry Forecast” looks at past ... Read More
-
Global Biosimilar Monoclonal Antibody Market Growth (Status and Outlook) 2023-2029
... clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are called biosimilar monoclonal antibodies. Biosimilar Monoclonal Antibodies refer to the biologic medical product ... Read More
-
Erythropoietin Drugs Market Size, Share & Trends Analysis Report By Type (Biologics, Biosimilars) By Product (Erythropoietin, Darbepoetin-alfa), By Application (Cancer, Renal Disease, Neurology), By Region, And Segment Forecasts, 2023 - 2030
... & Trends The global erythropoietin drugs market size is expected to reach USD 7.8 billion expanding at a CAGR of 1.5% from 2023 to 2030, according to a new report by Grand View Research, Inc., ... Read More
-
Global Biosimilars & Follow-on-biologics Market Growth (Status and Outlook) 2023-2029
... 2022, providing a comprehensive analysis by region and market sector of projected Biosimilars & Follow-on-biologics sales for 2023 through 2029. With Biosimilars & Follow-on-biologics sales broken down by region, market sector and sub-sector, this report ... Read More
-
Global G-CSF Biosimilars Market Growth 2023-2029
... looks at past sales and reviews total world G-CSF Biosimilars sales in 2022, providing a comprehensive analysis by region and market sector of projected G-CSF Biosimilars sales for 2023 through 2029. With G-CSF Biosimilars sales ... Read More
-
Global HGH Biosimilars Market Growth 2023-2029
... affect fat and mineral metabolism, and play a key role in human growth and development. Subcutaneous injection of about 80% was absorbed, 5 hours to reach the peak of blood drug concentration, the half-life of ... Read More
-
Global Biosimilars Insulin Market Growth 2023-2029
... and effectiveness. Biosimilars insulin is a type of biosimilars where it is indistinguishable to the reference insulin product and is already been approved by FDA or licensed. The producers of biosimilars use the similar manufacturing ... Read More
-
Global Biosimilar Testing and Development Services Market Growth (Status and Outlook) 2023-2029
... Testing and Development Services sales in 2022, providing a comprehensive analysis by region and market sector of projected Biosimilar Testing and Development Services sales for 2023 through 2029. With Biosimilar Testing and Development Services sales ... Read More
-
Generic Pharmaceuticals Market Size, Share & Trends Analysis Report By Type (Simple Generics, Specialty Generics, Biosimilars), By Route Of Administration, By Product, By Application, By Distribution Channel, By Region And Segment Forecasts, 2023 - 2030
... Generic Pharmaceuticals Market Growth & Trends The global generic pharmaceuticals market is expected to reach over USD 682.9 billion expanding at a CAGR of 8.3% from 2023 to 2030, according to a new study by ... Read More
-
Biosimilars Market Size Outlook in 2023 and Beyond: Market Trends, Insights, Growth Opportunities, Market Share and Forecasts by Types, Applications, Countries and Companies to 2030
... in the sector in 2023 and beyond. The Biosimilars market report analyzes the Biosimilars market growth opportunities, trends, insights, and market size outlook across types, applications, and countries. Biosimilars market dynamics including trends, drivers, growth ... Read More
-
Biosimilar Lymphocyte Modulator Market Size Outlook in 2023 and Beyond: Market Trends, Insights, Growth Opportunities, Market Share and Forecasts by Types, Applications, Countries and Companies to 2030
... to register solid growth in the sector in 2023 and beyond. The Biosimilar Lymphocyte Modulator market report analyzes the Biosimilar Lymphocyte Modulator market growth opportunities, trends, insights, and market size outlook across types, applications, and ... Read More
-
2023 Global Biosimilars Market Industry (2029 Outlook)
... three-year historical trend (2017-2020), a three-year forecast estimate trends (2021-2023), and a five-year outlook projection (2024-2029) for 46 countries. Market and product shipments include the total value of all products produced and shipped by all ... Read More
-
Global PEGylated Proteins Market Size study & Forecast, by Protein Type (Colony-stimulating factor, Interferons, Erythropoietin, Recombinant factor VII, Others), by Product & Services (Consumables, Services), by Application (Cancer, Autoimmune diseases, Hepatitis, Multiple sclerosis, Hemophilia, Gastrointestinal disorders, Others), by End-User (Pharmaceutical & biotechnology companies, Contract research organizations, Academic & research institutes), and Regional Analysis, 2022-2029
... disorders, Others), by End-User (Pharmaceutical & biotechnology companies, Contract research organizations, Academic & research institutes), and Regional Analysis, 2022-2029 Global PEGylated Proteins Market is valued at approximately USD 1.14 billion in 2021 and is anticipated ... Read More
-
Global Bioprocess Analyzers Market Size study & Forecast, by Product (Instrument and Consumables), Application (Antibiotics, Recombinant Proteins, Biosimilars, Other Applications), Type (Substrate Analysis, Metabolite Analysis, and Concentration Detection), and Regional Analysis, 2022-2029
... Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 10.1% over the forecast period 2022-2029. Bioprocess Analyzers help in the quick ... Read More
-
Biosimilars Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... the biosimilars market may be significant, and it has imposed a great challenge on the pharmaceutical companies focused on biosimilar development. The reduction in the approval by regulatory bodies of non-COVID therapeutics during the current ... Read More
-
Biosimilar Contract Manufacturing Market – Global Outlook & Forecast 2022-2027
... cannot afford life-saving medicines, putting their lives at risk. Producing potentially life-saving drugs that are more accessible and affordable can help today's patients live better lives for a prolonged period and minimize health inequality. Biologic ... Read More
-
Global Biosimilar Insulin Market Growth 2023-2029
... designed to be highly similar to the original, or reference, insulin product described in a patent. They are analogous to generic versions of small-molecule drugs and are developed by companies other than the reference product's ... Read More
-
Global Biosimilar Market Growth (Status and Outlook) 2023-2029
... manufactured by a different company. Biosimilar are officially approved versions of original "innovator" products and can manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval. ... Read More
-
Global Interferon Alpha-2a Biosimilar Market Growth 2023-2029
... DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent. An oral form is being developed by Amarillo Biosciences. LPI (LP Information)' newest research report, the “Interferon ... Read More
-
Global Biosimilar Drug Market Growth 2023-2029
... from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine. A biosimilar in this report is a ... Read More
-
Global Biologics and Biosimilars Market Growth 2023-2029
... derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine. A biosimilar in this report is ... Read More
-
2023 Global Forecast for Cardiac Safety Services Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... countries. The global market is expected to increase from USD xx billion in 2024 to USD xx billion by 2029, at a CAGR of xx% from 2024 to 2029. Estimates on equipment or material sales ... Read More
Research Assistance
